I would love to treat this question like a tutoring session, more than a direct answer!

I am doing a trend analysis for Amgen Inc, with Moderna as their competitor. I have gathered the following data into tables. I need to analyze the financial conditions, stability and trends. From these numbers, I see a fluctuation in stability, with a huge spurt of growth on the tail end of the pandemic.

1. It looks potentially like a good amount of liabilities were greated by both companies during periods of R&D based on their L/A growth rate. Does that seem right?
2. I need to also create a recommendation recommendation for whether or not the company is sustainable in the near future, and how to improive financial stability. If you could point me in the right direction, and which numbers to look at, it would be greatly appreciated!

I am here to learn. Thank you!

MODERNA	2018	2019	2020	2021	2022
Sales Growth Rate	-	-55.42%	+1234.34%	+2191.90%	+3.78%
COGS Growth Rate	-	+24.77%	+26.31%	+7,170.82%	+102.32%
Net Income Growth Rate	-	-32.19%	-45.34%	+1733.33%	-31.47%
Total Liabilities/Total Assests Growth Rate	+22.01%	+26.09%	+65.09%	+43.12%	26.70%

5-year period	AMGEN INC	MODERNA
Sales Growth Rate
COGS Growth Rate
Interest Expense Growth Rate
Net Income Growth Rate
Assets Total Growth Rate
Total Liabilities/Total Assets Growth Rates
Total Shareholders Equity/Total Assests

__I - - - _ I -"--" _ l. -_